甲状腺機能低下症の患者の生活の質 体系的なレビュー
Marianne Thvilum1, Sara Marcus Lind1, Eva Ebbehoj1
1Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 165, 8200 Aarhus N, Denmark.
European journal of endocrinology
|September 5, 2025
まとめ
甲状腺機能低下症の患者は,レボチロキシン治療にもかかわらず,生活の質が低下しています. この体系的なレビューは 精神的健康,身体的健康,社会的役割に関する 持続的な問題を強調しています 最適な治療法であってもです
科学分野:
- 内分泌学と代謝
- 臨床研究
- 健康 成果 研究
背景:
- レボチロキシン (LT4) で治療された甲状腺機能低下症の患者では,症状が持続し,生活の質 (QoL) が低下することが増加しています.
- 治療中の甲状腺機能低下症における長期的QOLの評価を理解することは,患者のケアにとって極めて重要です.
研究 の 目的:
- 長期間レボチロキシン治療を受けている大人の甲状腺機能低下症,特にハシモトの甲状腺炎 (HT) または先天性甲状腺機能低下症 (CH) の生活の質に関する既存の文献を体系的にレビューし,メタ分析する.
主な方法:
- キーワード"甲状腺機能低下と生活の質"を使って,PubMedとEmbaseで体系的な文献検索が行われました.
- レボチロキシンで少なくとも6ヶ月間治療されたHTまたはCHの成人の患者に焦点を当てた研究が含まれています.
- 生活の質の領域 (精神的幸福,身体的幸福,社会的役割) を評価し,ランダム効果モデルを使用してメタ分析を行った.
主要な成果:
- このレビューには17件の研究 (HTに関する14件,CHに関する3件) が含まれていた.
- 精神的幸福度 (10 研究) と身体的幸福度 (10 研究) の低下が頻繁に報告されました.
- 社会的な役割の障害は7つの研究で認められた. 方法論的な欠陥は13の研究に存在したが,結論は堅実な研究のメタ解析によって支持された.
結論:
- 方法論的な限界にもかかわらず,甲状腺機能低下症の患者の生活の質は著しく低下しています.
- 将来の研究は,残留バイアスに対処し,疾患の病因,持続時間,併発症などの要因を調査し,不十分な治療応答の患者グループを特定し,QOLを改善する必要があります.
関連する概念動画
Hypertension III: Clinical Manifestations and Diagnostic Studies
48
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48
Synthesis and Regulation of Thyroid Hormones
5.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.1K
COPD: Management Using Bronchodilators and Corticosteroids
300
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
300
Functions of Thyroid Hormones
3.1K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
3.1K
Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Hypertension IV: Drug Therapy and Lifestyle Modifications
37
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
37


